Adedokun, L., & Burke, C. (2016). Cost-Effectiveness of Ranibizumab Versus Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion: A UK Healthcare Perspective. Adv Ther.
Chicago Style CitationAdedokun, Lola, i Colin Burke. "Cost-Effectiveness of Ranibizumab Versus Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion: A UK Healthcare Perspective." Adv Ther 2016.
Cita MLAAdedokun, Lola, i Colin Burke. "Cost-Effectiveness of Ranibizumab Versus Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion: A UK Healthcare Perspective." Adv Ther 2016.
Atenció: Aquestes cites poden no estar 100% correctes.